| UniProt ID | FCHO2_HUMAN | |
|---|---|---|
| UniProt AC | Q0JRZ9 | |
| Protein Name | F-BAR domain only protein 2 | |
| Gene Name | FCHO2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 810 | |
| Subcellular Localization |
Membrane, clathrin-coated pit Peripheral membrane protein Cytoplasmic side. Associated with forming but not mature clathrin-coated vesicles. The recruitment to coated-pits precede the one of clathrin and the adaptor protein complex AP-2 (By similar |
|
| Protein Description | Functions in an early step of clathrin-mediated endocytosis. Has both a membrane binding/bending activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. Has a lipid-binding activity with a preference for membranes enriched in phosphatidylserine and phosphoinositides (Pi(4,5) biphosphate) like the plasma membrane. Its membrane-bending activity might be important for the subsequent action of clathrin and adaptors in the formation of clathrin-coated vesicles. Involved in adaptor protein complex AP-2-dependent endocytosis of the transferrin receptor, it also functions in the AP-2-independent endocytosis of the LDL receptor.. | |
| Protein Sequence | MVMAYFVENFWGEKNSGFDVLYHNMKHGQISTKELADFVRERATIEEAYSRSMTKLAKSASNYSQLGTFAPVWDVFKTSTEKLANCHLDLVRKLQELIKEVQKYGEEQVKSHKKTKEEVAGTLEAVQTIQSITQALQKSKENYNAKCVEQERLKKEGATQREIEKAAVKSKKATDTYKLYVEKYALAKADFEQKMTETAQKFQDIEETHLIHIKEIIGSLSNAIKEIHLQIGQVHEEFINNMANTTVESLIQKFAESKGTGKERPGLIEFEECDTASAVEGIKPRKRKTFALPGIIKKEKDAESVECPDADSLNIPDVDEEGYSIKPETNQNDTKENHFYSSSDSDSEDEEPKKYRIEIKPMHPNNSHHTMASLDELKVSIGNITLSPAISRHSPVQMNRNLSNEELTKSKPSAPPNEKGTSDLLAWDPLFGPSLDSSSSSSLTSSSSARPTTPLSVGTIVPPPRPASRPKLTSGKLSGINEIPRPFSPPVTSNTSPPPAAPLARAESSSSISSSASLSAANTPTVGVSRGPSPVSLGNQDTLPVAVALTESVNAYFKGADPTKCIVKITGDMTMSFPSGIIKVFTSNPTPAVLCFRVKNISRLEQILPNAQLVFSDPSQCDSNTKDFWMNMQAVTVYLKKLSEQNPAASYYNVDVLKYQVSSNGIQSTPLNLATYWKCSASTTDLRVDYKYNPEAMVAPSVLSNIQVVVPVDGGVTNMQSLPPAIWNAEQMKAFWKLSSISEKSENGGSGSLRAKFDLSEGPSKPTTLAVQFLSEGSTLSGVDFELVGTGYRLSLIKKRFATGRYLADC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 22 | Phosphorylation | NSGFDVLYHNMKHGQ CCCCCEEEECCCCCC | 7.32 | 21253578 | |
| 26 | Malonylation | DVLYHNMKHGQISTK CEEEECCCCCCCCHH | 50.31 | 26320211 | |
| 44 | O-linked_Glycosylation | DFVRERATIEEAYSR HHHHHHHHHHHHHHH | 34.83 | 30379171 | |
| 44 | Phosphorylation | DFVRERATIEEAYSR HHHHHHHHHHHHHHH | 34.83 | 18452278 | |
| 55 | Ubiquitination | AYSRSMTKLAKSASN HHHHHHHHHHHHHCC | 37.49 | 22817900 | |
| 58 | Ubiquitination | RSMTKLAKSASNYSQ HHHHHHHHHHCCCHH | 57.92 | 21890473 | |
| 58 | Ubiquitination | RSMTKLAKSASNYSQ HHHHHHHHHHCCCHH | 57.92 | 22817900 | |
| 58 (in isoform 1) | Ubiquitination | - | 57.92 | 21890473 | |
| 58 (in isoform 2) | Ubiquitination | - | 57.92 | 21890473 | |
| 59 | Phosphorylation | SMTKLAKSASNYSQL HHHHHHHHHCCCHHC | 31.18 | 28270605 | |
| 61 | Phosphorylation | TKLAKSASNYSQLGT HHHHHHHCCCHHCCC | 43.31 | 28270605 | |
| 63 | Phosphorylation | LAKSASNYSQLGTFA HHHHHCCCHHCCCCC | 8.69 | 28270605 | |
| 64 | Phosphorylation | AKSASNYSQLGTFAP HHHHCCCHHCCCCCC | 24.15 | 28270605 | |
| 68 | Phosphorylation | SNYSQLGTFAPVWDV CCCHHCCCCCCHHHH | 25.80 | 28270605 | |
| 77 | Ubiquitination | APVWDVFKTSTEKLA CCHHHHHHHCHHHHH | 41.22 | 32015554 | |
| 82 | Acetylation | VFKTSTEKLANCHLD HHHHCHHHHHHCCHH | 53.65 | 26051181 | |
| 99 | 2-Hydroxyisobutyrylation | RKLQELIKEVQKYGE HHHHHHHHHHHHHCH | 65.54 | - | |
| 99 | Acetylation | RKLQELIKEVQKYGE HHHHHHHHHHHHHCH | 65.54 | 178226245 | |
| 99 | Ubiquitination | RKLQELIKEVQKYGE HHHHHHHHHHHHHCH | 65.54 | 29967540 | |
| 103 | Acetylation | ELIKEVQKYGEEQVK HHHHHHHHHCHHHHH | 61.47 | 7711281 | |
| 103 | Ubiquitination | ELIKEVQKYGEEQVK HHHHHHHHHCHHHHH | 61.47 | 33845483 | |
| 165 | Ubiquitination | ATQREIEKAAVKSKK CCHHHHHHHHHHCCC | 47.51 | - | |
| 174 | Phosphorylation | AVKSKKATDTYKLYV HHHCCCCCCHHHHHH | 37.44 | 29083192 | |
| 176 | Phosphorylation | KSKKATDTYKLYVEK HCCCCCCHHHHHHHH | 20.43 | 29083192 | |
| 177 | Phosphorylation | SKKATDTYKLYVEKY CCCCCCHHHHHHHHH | 11.21 | 29083192 | |
| 180 | Phosphorylation | ATDTYKLYVEKYALA CCCHHHHHHHHHHHH | 11.47 | 29083192 | |
| 188 | Ubiquitination | VEKYALAKADFEQKM HHHHHHHHCHHHHHH | 49.71 | 29967540 | |
| 194 | Ubiquitination | AKADFEQKMTETAQK HHCHHHHHHHHHHHH | 40.36 | 32015554 | |
| 223 | Ubiquitination | IIGSLSNAIKEIHLQ HHHHHHHHHHHHHHH | 15.74 | 22817900 | |
| 225 | Ubiquitination | GSLSNAIKEIHLQIG HHHHHHHHHHHHHHH | 48.48 | 22817900 | |
| 227 | Ubiquitination | LSNAIKEIHLQIGQV HHHHHHHHHHHHHHH | 3.14 | 21963094 | |
| 229 | Ubiquitination | NAIKEIHLQIGQVHE HHHHHHHHHHHHHHH | 4.95 | 21963094 | |
| 248 | Ubiquitination | NMANTTVESLIQKFA HHCCHHHHHHHHHHH | 37.42 | 23000965 | |
| 250 | Ubiquitination | ANTTVESLIQKFAES CCHHHHHHHHHHHHH | 2.81 | 23000965 | |
| 251 | Ubiquitination | NTTVESLIQKFAESK CHHHHHHHHHHHHHC | 6.11 | 23000965 | |
| 253 | Ubiquitination | TVESLIQKFAESKGT HHHHHHHHHHHHCCC | 39.28 | 23000965 | |
| 255 | Ubiquitination | ESLIQKFAESKGTGK HHHHHHHHHHCCCCC | 27.47 | 23000965 | |
| 258 | Ubiquitination | IQKFAESKGTGKERP HHHHHHHCCCCCCCC | 52.58 | 22817900 | |
| 262 | Acetylation | AESKGTGKERPGLIE HHHCCCCCCCCCCEE | 50.84 | 26051181 | |
| 262 | Ubiquitination | AESKGTGKERPGLIE HHHCCCCCCCCCCEE | 50.84 | 21890473 | |
| 264 | Ubiquitination | SKGTGKERPGLIEFE HCCCCCCCCCCEEEE | 33.79 | 21890473 | |
| 264 | Ubiquitination | SKGTGKERPGLIEFE HCCCCCCCCCCEEEE | 33.79 | 21890473 | |
| 283 | Acetylation | ASAVEGIKPRKRKTF CHHCCCCCCCCCCCC | 50.02 | 26051181 | |
| 283 | Ubiquitination | ASAVEGIKPRKRKTF CHHCCCCCCCCCCCC | 50.02 | 23000965 | |
| 286 | Ubiquitination | VEGIKPRKRKTFALP CCCCCCCCCCCCCCC | 67.77 | 23000965 | |
| 288 | Ubiquitination | GIKPRKRKTFALPGI CCCCCCCCCCCCCCC | 51.54 | 23000965 | |
| 289 | Phosphorylation | IKPRKRKTFALPGII CCCCCCCCCCCCCCE | 20.41 | 27422710 | |
| 297 | Sumoylation | FALPGIIKKEKDAES CCCCCCEECCCCCCC | 53.62 | 28112733 | |
| 297 | Ubiquitination | FALPGIIKKEKDAES CCCCCCEECCCCCCC | 53.62 | 21890473 | |
| 297 (in isoform 1) | Ubiquitination | - | 53.62 | 21890473 | |
| 297 (in isoform 2) | Ubiquitination | - | 53.62 | 21890473 | |
| 304 | Phosphorylation | KKEKDAESVECPDAD ECCCCCCCCCCCCHH | 25.57 | 26657352 | |
| 312 | Phosphorylation | VECPDADSLNIPDVD CCCCCHHHCCCCCCC | 25.65 | 25159151 | |
| 323 | Phosphorylation | PDVDEEGYSIKPETN CCCCCCCCCCCCCCC | 15.53 | 20873877 | |
| 324 | Phosphorylation | DVDEEGYSIKPETNQ CCCCCCCCCCCCCCC | 34.69 | 20873877 | |
| 329 | Phosphorylation | GYSIKPETNQNDTKE CCCCCCCCCCCCCCC | 51.11 | 23927012 | |
| 334 | Phosphorylation | PETNQNDTKENHFYS CCCCCCCCCCCCCCC | 48.05 | 23927012 | |
| 340 | Phosphorylation | DTKENHFYSSSDSDS CCCCCCCCCCCCCCC | 10.49 | 24275569 | |
| 341 | Phosphorylation | TKENHFYSSSDSDSE CCCCCCCCCCCCCCC | 23.56 | 25849741 | |
| 342 | Phosphorylation | KENHFYSSSDSDSED CCCCCCCCCCCCCCC | 27.13 | 25849741 | |
| 343 | Phosphorylation | ENHFYSSSDSDSEDE CCCCCCCCCCCCCCC | 34.88 | 25849741 | |
| 345 | Phosphorylation | HFYSSSDSDSEDEEP CCCCCCCCCCCCCCC | 45.01 | 25849741 | |
| 347 | Phosphorylation | YSSSDSDSEDEEPKK CCCCCCCCCCCCCCE | 51.39 | 25849741 | |
| 354 | Phosphorylation | SEDEEPKKYRIEIKP CCCCCCCEEEEEEEC | 50.94 | 32142685 | |
| 361 | Phosphorylation | KYRIEIKPMHPNNSH EEEEEEECCCCCCCC | 31.79 | 32142685 | |
| 367 | Phosphorylation | KPMHPNNSHHTMASL ECCCCCCCCCCCCCH | 24.24 | 28348404 | |
| 370 | Phosphorylation | HPNNSHHTMASLDEL CCCCCCCCCCCHHHC | 14.71 | 32645325 | |
| 380 | O-linked_Glycosylation | SLDELKVSIGNITLS CHHHCEEEECCEEEC | 24.16 | 30379171 | |
| 380 | Phosphorylation | SLDELKVSIGNITLS CHHHCEEEECCEEEC | 24.16 | 25159151 | |
| 385 | Phosphorylation | KVSIGNITLSPAISR EEEECCEEECCCHHH | 25.78 | 30266825 | |
| 387 | Phosphorylation | SIGNITLSPAISRHS EECCEEECCCHHHCC | 12.02 | 19664994 | |
| 391 | O-linked_Glycosylation | ITLSPAISRHSPVQM EEECCCHHHCCCCCC | 26.50 | 30379171 | |
| 391 | Phosphorylation | ITLSPAISRHSPVQM EEECCCHHHCCCCCC | 26.50 | 29255136 | |
| 394 | Phosphorylation | SPAISRHSPVQMNRN CCCHHHCCCCCCCCC | 26.17 | 22167270 | |
| 403 | Phosphorylation | VQMNRNLSNEELTKS CCCCCCCCHHHHHCC | 45.83 | 29255136 | |
| 408 | Phosphorylation | NLSNEELTKSKPSAP CCCHHHHHCCCCCCC | 36.23 | 30266825 | |
| 410 | Phosphorylation | SNEELTKSKPSAPPN CHHHHHCCCCCCCCC | 44.56 | 24275569 | |
| 444 | Phosphorylation | SSSSSSLTSSSSARP CCCCCCCCCCCCCCC | 28.63 | 27251275 | |
| 445 | Phosphorylation | SSSSSLTSSSSARPT CCCCCCCCCCCCCCC | 33.25 | 27251275 | |
| 446 | Phosphorylation | SSSSLTSSSSARPTT CCCCCCCCCCCCCCC | 24.07 | 27251275 | |
| 447 | Phosphorylation | SSSLTSSSSARPTTP CCCCCCCCCCCCCCC | 27.99 | 28348404 | |
| 448 | Phosphorylation | SSLTSSSSARPTTPL CCCCCCCCCCCCCCC | 30.19 | 28348404 | |
| 452 | Phosphorylation | SSSSARPTTPLSVGT CCCCCCCCCCCCCEE | 35.18 | 25850435 | |
| 453 | Phosphorylation | SSSARPTTPLSVGTI CCCCCCCCCCCCEEE | 25.55 | 26657352 | |
| 455 | Phosphorylation | SARPTTPLSVGTIVP CCCCCCCCCCEEECC | 6.43 | 32142685 | |
| 456 | Phosphorylation | ARPTTPLSVGTIVPP CCCCCCCCCEEECCC | 21.50 | 20873877 | |
| 459 | Phosphorylation | TTPLSVGTIVPPPRP CCCCCCEEECCCCCC | 19.35 | 20873877 | |
| 460 | Phosphorylation | TPLSVGTIVPPPRPA CCCCCEEECCCCCCC | 3.44 | 32142685 | |
| 468 | Phosphorylation | VPPPRPASRPKLTSG CCCCCCCCCCCCCCC | 52.37 | 26657352 | |
| 473 | Phosphorylation | PASRPKLTSGKLSGI CCCCCCCCCCCCCCC | 41.37 | 21406692 | |
| 474 | Phosphorylation | ASRPKLTSGKLSGIN CCCCCCCCCCCCCCC | 44.35 | 22496350 | |
| 478 | Phosphorylation | KLTSGKLSGINEIPR CCCCCCCCCCCCCCC | 40.90 | 23927012 | |
| 488 | Phosphorylation | NEIPRPFSPPVTSNT CCCCCCCCCCCCCCC | 30.86 | 29255136 | |
| 492 | Phosphorylation | RPFSPPVTSNTSPPP CCCCCCCCCCCCCCC | 23.25 | 29255136 | |
| 493 | Phosphorylation | PFSPPVTSNTSPPPA CCCCCCCCCCCCCCC | 38.04 | 29255136 | |
| 495 | Phosphorylation | SPPVTSNTSPPPAAP CCCCCCCCCCCCCCC | 42.23 | 29255136 | |
| 496 | Phosphorylation | PPVTSNTSPPPAAPL CCCCCCCCCCCCCCC | 39.39 | 25159151 | |
| 508 | Phosphorylation | APLARAESSSSISSS CCCCCCCCCCCCCCC | 34.24 | 30278072 | |
| 509 | Phosphorylation | PLARAESSSSISSSA CCCCCCCCCCCCCCC | 21.43 | 30278072 | |
| 510 | Phosphorylation | LARAESSSSISSSAS CCCCCCCCCCCCCCC | 40.76 | 30278072 | |
| 511 | Phosphorylation | ARAESSSSISSSASL CCCCCCCCCCCCCCC | 28.56 | 23911959 | |
| 513 | Phosphorylation | AESSSSISSSASLSA CCCCCCCCCCCCCCC | 21.86 | 30278072 | |
| 514 | Phosphorylation | ESSSSISSSASLSAA CCCCCCCCCCCCCCC | 28.40 | 30576142 | |
| 515 | Phosphorylation | SSSSISSSASLSAAN CCCCCCCCCCCCCCC | 18.32 | 30278072 | |
| 517 | Phosphorylation | SSISSSASLSAANTP CCCCCCCCCCCCCCC | 25.46 | 30278072 | |
| 519 | Phosphorylation | ISSSASLSAANTPTV CCCCCCCCCCCCCCE | 23.88 | 30278072 | |
| 523 | Phosphorylation | ASLSAANTPTVGVSR CCCCCCCCCCEECCC | 18.66 | 28857561 | |
| 525 | Phosphorylation | LSAANTPTVGVSRGP CCCCCCCCEECCCCC | 28.05 | 23186163 | |
| 529 | Phosphorylation | NTPTVGVSRGPSPVS CCCCEECCCCCCCCC | 26.12 | 23186163 | |
| 533 | Phosphorylation | VGVSRGPSPVSLGNQ EECCCCCCCCCCCCC | 40.53 | 30278072 | |
| 536 | Phosphorylation | SRGPSPVSLGNQDTL CCCCCCCCCCCCCCC | 33.66 | 30278072 | |
| 542 | Phosphorylation | VSLGNQDTLPVAVAL CCCCCCCCCCHHHHH | 24.17 | 23663014 | |
| 550 | Phosphorylation | LPVAVALTESVNAYF CCHHHHHHHHHHHHH | 19.24 | 25850435 | |
| 552 | Phosphorylation | VAVALTESVNAYFKG HHHHHHHHHHHHHCC | 18.55 | 25850435 | |
| 556 | Phosphorylation | LTESVNAYFKGADPT HHHHHHHHHCCCCCC | 10.71 | 26330541 | |
| 608 | Ubiquitination | ISRLEQILPNAQLVF HHHHHHHCCCCEEEE | 2.40 | 29967540 | |
| 616 | Phosphorylation | PNAQLVFSDPSQCDS CCCEEEECCHHHCCC | 40.92 | 28387310 | |
| 641 | Ubiquitination | AVTVYLKKLSEQNPA HHHHHHHHHHHCCCC | 55.43 | 29967540 | |
| 651 | Phosphorylation | EQNPAASYYNVDVLK HCCCCHHEECEEEEE | 8.37 | - | |
| 676 | Phosphorylation | TPLNLATYWKCSAST CCEEEECEEECCCCC | 9.39 | - | |
| 678 | Acetylation | LNLATYWKCSASTTD EEEECEEECCCCCCC | 14.11 | 7704225 | |
| 682 | Phosphorylation | TYWKCSASTTDLRVD CEEECCCCCCCCEEE | 18.62 | 22798277 | |
| 683 | Phosphorylation | YWKCSASTTDLRVDY EEECCCCCCCCEEEC | 24.85 | 28348404 | |
| 684 | Phosphorylation | WKCSASTTDLRVDYK EECCCCCCCCEEECC | 30.46 | 24961811 | |
| 711 | Ubiquitination | SNIQVVVPVDGGVTN HCCEEEEECCCCCCC | 13.58 | 32015554 | |
| 739 | Phosphorylation | MKAFWKLSSISEKSE HHHHHHHHHCCCCCC | 23.15 | 27251275 | |
| 740 | Phosphorylation | KAFWKLSSISEKSEN HHHHHHHHCCCCCCC | 40.34 | 27251275 | |
| 744 | Ubiquitination | KLSSISEKSENGGSG HHHHCCCCCCCCCCC | 57.17 | 32015554 | |
| 795 | Phosphorylation | VGTGYRLSLIKKRFA ECCCEEHHHHHHHHC | 21.03 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FCHO2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FCHO2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FCHO2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| EPS15_HUMAN | EPS15 | physical | 21762413 | |
| DAB2_HUMAN | DAB2 | physical | 22323290 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488; SER-510 ANDSER-511, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387 AND SER-403, ANDMASS SPECTROMETRY. | |